The U.S. Department of Veterans Affairs (VA) awarded a firm fixed-price purchase order to Mckesson Plasma And Biologics LLC, a subsidiary of Mckesson Corporation, for the delivery of belzutifan 40mg capsules. The contract, valued at $22,051.39, has an ultimate completion date of April 30, 2025. The award was made through the Veterans Integrated Service Network 2 (VISN 2), a regional network within the VA's healthcare system. The contract does not have a set-aside designation. Mckesson Plasma And Biologics LLC is a for-profit limited liability company that specializes in distributing a wide range of pharmaceutical products, including specialty medications and biologics, to support healthcare services across various federal agencies, primarily the VA and the Department of Health and Human Services' National Institutes of Health.
Generated 2/5/25, 9:20 AM